Antibodies directed against tau protein, including semorinemab, tilavonemab, and gosuranemab, have shown unpromising preliminary results and fail to improve global patient functionality (Monteiro et al., 2023)
People with type 2 diabetes who need help with blood sugar control or who also have risk factors for cardiovascular disease are candidates for these medications, according to Diala Alatassi, MD , a double board-certified internal and obesity medicine physician at Endeavor Health in Elmhurst, IL
Furthermore, a comprehensive review published in the Journal of Translational Medicine proposed a unifying model for ME/CFS and Long COVID, highlighting how viral infections (like SARS-CoV-2 or Epstein-Barr Virus) trigger a cascade of immune exhaustion, micro-clotting, and severe oxidative stress
Rapid Weight Loss vs
Complete genome sequence of Burkholderia cenocepacia K56-2, an opportunistic pathogen